Voyager Therapeutics (VYGR) announced the appointment of Toby Ferguson, M.D., Ph.D., as Chief Medical Officer, effective March 25, 2024. He most recently served as Vice President, Head of Neuromuscular Development Unit at Biogen (BIIB).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VYGR:
- Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
- Voyager Therapeutics initiated with a Buy at Citi
- Voyager Therapeutics reports Q4 EPS $1.25, consensus (29c)
- Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
- Voyager Therapeutics reports selection of gene therapy development candidate
